Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohan Biyani

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 9, 2022
Predictors of serum vancomycin levels in peritoneal dialysis-associated peritonitisErin Deacon, Mark Canney, Brendan McCormick, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 25, 2009
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: systematic review and meta-analysis of randomized controlled trialsAyub Akbari, Greg Knoll, Dean Ferguson, et al.
BMC Nephrology|December 10, 2015
Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort studySimon Leung, Brendan McCormick, Jessica Wagner, et al.
Kidney International Reports|December 18, 2023
The Association Between Serum Vancomycin Level and Clinical Outcome in Patients With Peritoneal Dialysis Associated PeritonitisErin Deacon, Mark Canney, Brendan McCormick, et al.
Canadian Journal of Kidney Health and Disease|March 28, 2020
Prediction of Progression in Polycystic Kidney Disease Using the Kidney Failure Risk Equation and Ultrasound ParametersAyub Akbari, Navdeep Tangri, Pierre A Brown, et al.
Canadian Journal of Kidney Health and Disease|September 7, 2018
The Risk of Adverse Events in Patients With Polycystic Kidney Disease With Advanced Chronic Kidney DiseaseSonali de Chickera, Ayub Akbari, Adeera Levin, et al.
Canadian Journal of Kidney Health and Disease|July 7, 2018
End-Stage Kidney Disease in Patients With Autosomal Dominant Polycystic Kidney Disease: A 12-Year Study Based on the Canadian Organ Replacement RegistryBrandon Budhram, Ayub Akbari, Pierre Brown, et al.
Kidney Medicine|February 21, 2025
Spot Versus 24-Hour Urine Osmolality Measurement in Autosomal Dominant Polycystic Kidney Disease: A Diagnostic Test StudyAyub Akbari, Sriram Sriperumbuduri, Shreepryia Mangalgi, et al.
BMC Nephrology|April 8, 2017
Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional studyAmber O Molnar, Mohan Biyani, Ian Hammond, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 15, 2020
Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKDGregory L Hundemer, Navdeep Tangri, Manish M Sood, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 9, 2022
Predictors of serum vancomycin levels in peritoneal dialysis-associated peritonitisErin Deacon, Mark Canney, Brendan McCormick, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 25, 2009
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: systematic review and meta-analysis of randomized controlled trialsAyub Akbari, Greg Knoll, Dean Ferguson, et al.
BMC Nephrology|December 10, 2015
Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort studySimon Leung, Brendan McCormick, Jessica Wagner, et al.
Kidney International Reports|December 18, 2023
The Association Between Serum Vancomycin Level and Clinical Outcome in Patients With Peritoneal Dialysis Associated PeritonitisErin Deacon, Mark Canney, Brendan McCormick, et al.
Canadian Journal of Kidney Health and Disease|March 28, 2020
Prediction of Progression in Polycystic Kidney Disease Using the Kidney Failure Risk Equation and Ultrasound ParametersAyub Akbari, Navdeep Tangri, Pierre A Brown, et al.
Canadian Journal of Kidney Health and Disease|September 7, 2018
The Risk of Adverse Events in Patients With Polycystic Kidney Disease With Advanced Chronic Kidney DiseaseSonali de Chickera, Ayub Akbari, Adeera Levin, et al.
Canadian Journal of Kidney Health and Disease|July 7, 2018
End-Stage Kidney Disease in Patients With Autosomal Dominant Polycystic Kidney Disease: A 12-Year Study Based on the Canadian Organ Replacement RegistryBrandon Budhram, Ayub Akbari, Pierre Brown, et al.
Kidney Medicine|February 21, 2025
Spot Versus 24-Hour Urine Osmolality Measurement in Autosomal Dominant Polycystic Kidney Disease: A Diagnostic Test StudyAyub Akbari, Sriram Sriperumbuduri, Shreepryia Mangalgi, et al.
BMC Nephrology|April 8, 2017
Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional studyAmber O Molnar, Mohan Biyani, Ian Hammond, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 15, 2020
Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKDGregory L Hundemer, Navdeep Tangri, Manish M Sood, et al.
Pageof 3